Fundraising Fox
Genialis
Boston, US · Founded 2015 · Delaware corporation · 32 employees on LinkedIn · 9 known investors
Find your way into Genialis
Sign up to see every warm intro you have to Genialis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genialis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.
Founders & leadership
Genialis was founded in 2015 by Miha Štajdohar, Rafael Rosengarten, and Luka Ausec.
Board
Investors · 9
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: Debiopharm Innovation Fund's portfolio page · funding news · hlth.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: ScaleX Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$14.4M disclosed across 3 rounds · 2017–2025
- $2.3MSeedNov 2017 · 2 sources
First Star Venture Capital (lead), Redalpine Venture Capital (lead), Pikas d.o.o.
Source ↗
▶$700KraisedDec 2025 · 2 investors · BiotechnologyRule 506(b)
- Ita LuDirector
- Cedric Hermann OdjeDirector
- Elia StupkaDirector
- Krista McKerracherDirector
- Miha StajdoharExecutive Officer, Director
- Rafael RosengartenExecutive Officer, Director
- Luka AusecExecutive Officer
- Offering amount
- $3M
- Amount sold
- $700K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.4MraisedJan 2023 · 10 investors · BiotechnologyRule 506(b)
- Nadine GeiserDirector
- Elia StupkaDirector
- Ita LuDirector
- Luka AusecExecutive Officer
- Rafael RosengartenExecutive Officer, Director
- Hamzeh Abdul-HadiDirector
- Drew VolpeDirector
- Miha StajdoharExecutive Officer, Director
- Tjasa Krisper KutinExecutive Officer
- Offering amount
- $13.9M
- Amount sold
- $11.4M
- Proceeds to insiders
- $1.4M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Genialis.
In the news
Frequently asked questions
- What does Genialis do?
- Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.
- Who founded Genialis?
- Genialis was founded by Miha Štajdohar, Rafael Rosengarten, Luka Ausec in 2015.
- Who are Genialis's investors?
- Genialis's investors include Angelini Ventures, Taiwania Capital, Debiopharm Innovation Fund, First Star Ventures, ScaleX Ventures, redalpine.
- How much funding has Genialis raised?
- Genialis has disclosed $14.4M raised across 3 rounds.
- Where is Genialis headquartered?
- Genialis is headquartered in Boston, US.